Work

Correlation between overall response rate and progression-free survival/overall survival in comparative trials involving targeted therapies in molecularly enriched populations.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.3588

Authors: Benjamin J. Solomon, Herbert H. F. Loong, Yvonne J. Summers, Zachary M Thomas, Pearl Plernjit French, Boris K. Lin, Andreas Sashegyi, Juergen Wolf, James Chih-Hsin Yang, Alexander E. Drilon

Institutions: Peter MacCallum Cancer Centre, Chinese University of Hong Kong, The Christie Hospital, The Christie NHS Foundation Trust, Eli Lilly (United States), University Hospital Cologne, National Taiwan University Hospital, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Eli Lilly and Company

OpenAlex ID: W3029204558

Cites:

Cited by: 2

Related to: 10